Published in Nephrol Dial Transplant on January 01, 1992
Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature (1995) 6.20
Experience with human growth hormone in Great Britain: the report of the MRC Working Party. Clin Endocrinol (Oxf) (1979) 4.42
Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet (1986) 4.04
Iron absorption and loading in beta-thalassaemia intermedia. Lancet (1979) 1.66
The international reference preparation of erythropoietin. Bull World Health Organ (1966) 1.60
Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes. Leukemia (2002) 1.59
Prevention of iron loading in transfusion-dependent thalassaemia. Lancet (1978) 1.47
In vivo studies on the relationship between intestinal iron (Fe3+) absorption, hypoxia and erythropoiesis in the mouse. Br J Haematol (1988) 1.39
Plasma ferritin determination as a diagnostic tool. West J Med (1986) 1.34
Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods (1987) 1.21
Immunoreactive erythropoietin in serum. I. Evidence for the validity of the assay method and the physiological relevance of estimates. Br J Haematol (1982) 1.19
Iron overload in mild sideroblastic anaemias. Lancet (1983) 1.06
The effect of erythroid hyperplasia on iron balance. Blood (1988) 1.06
Ferrioxamine excretion in iron-loaded man. Blood (1982) 1.06
Development of the immune response in the foetal and newborn rhesus monkey. I. Response to bovine serum albumin. Immunology (1966) 1.05
Microcytosis, iron deficiency, and thalassaemia in preschool children. Arch Dis Child (1990) 1.05
Collaborative study of estimates by radioimmunoassay of insulin concentrations in plasma samples examined in groups of five or six laboratories. J Endocrinol (1969) 1.03
Serum erythropoietin in humans at high altitude and its relation to plasma renin. J Appl Physiol (1985) (1985) 0.99
Integration of e-learning resources into a medical school curriculum. Med Teach (2011) 0.98
Relation of "lymphoid" phenotype and response to chemotherapy incorporating vincristine-prednisolone in the acute phase of Ph1 positive leukemia. Cancer (1979) 0.95
Iron chelation using subcutaneous infusions of diethylene triamine penta-acetic acid (DTPA). Scand J Haematol (1986) 0.94
Subcutaneous erythropoietin and peritoneal dialysis. Lancet (1989) 0.93
Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia. Clin Sci (Lond) (1985) 0.92
Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility. Lancet (2003) 0.92
Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes. Haematologica (2001) 0.90
Hepatocyte iron kinetics in the rat explored with an iron chelator. Br J Haematol (1982) 0.90
Giant lymph node hyperplasia (Castleman's disease) of the mesentery. Observations on the associated anemia. Gastroenterology (1984) 0.89
Desferrioxamine-induced iron excretion in humans. Baillieres Clin Haematol (1989) 0.89
Changes in serum immunoreactive erythropoietin during the menstrual cycle and normal pregnancy. Br J Obstet Gynaecol (1983) 0.88
The second international reference preparation of erythropoietin, human, urinary, for bioassay. Bull World Health Organ (1972) 0.87
Evaluation of building ventilation systems. Am Ind Hyg Assoc J (1986) 0.87
Metalworking fluid exposures in small machine shops: an overview. AIHAJ (2001) 0.86
Microcytic anaemia in juvenile chronic arthritis. Scand J Rheumatol (1987) 0.86
Iron homeostasis and the assessment of iron status. Ann Clin Biochem (1998) 0.86
Studies of erythroblast function in congenital dyserythropoietic anaemia, type I: evidence of impaired DNA, RNA, and protein synthesis and unbalanced globin chain synthesis in ultrastructurally abnormal cells. J Clin Pathol (1986) 0.85
Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats. J Clin Pathol (1987) 0.85
Antenatal fetal heart rate variation in relation to the respiratory and metabolic status of the compromised human fetus. Br J Obstet Gynaecol (1988) 0.85
Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication. Psychol Med (1978) 0.85
Development of a multiplex ARMS test for mutations in the HFE gene associated with hereditary haemochromatosis. J Clin Pathol (1998) 0.85
Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients. Clin Nephrol (1997) 0.84
Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis. N Engl J Med (1986) 0.84
Gonadotropin secretion abnormalities in chronic schizophrenia. Psychol Med (1982) 0.84
Diurnal variation of serum immunomoreactive erythropoietin in a normal subject. Clin Endocrinol (Oxf) (1982) 0.84
Mechanism of anaemia in resistant visceral leishmaniasis. Ann Trop Med Parasitol (1986) 0.83
Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias. Clin Sci Mol Med (1978) 0.83
Erythrocyte membrane modification in malignant diseases of myeloid and lymphoreticular tissues. I. Tn-polyagglutination in acute myelocytic leukaemia. Br J Haematol (1976) 0.82
Iron metabolism in thalassemia. Birth Defects Orig Artic Ser (1988) 0.81
Regulation of iron absorption in iron loaded subjects with end stage renal disease: effects of treatment with recombinant human erythropoietin and reduction of iron stores. Br J Haematol (1992) 0.81
Iron absorption in iron-loading anaemias: Effect of subcutaneous desferrioxamine infusions. Lancet (1977) 0.81
The anaemia of Plasmodium falciparum malaria. Ciba Found Symp (1983) 0.81
The international reference preparation of human pituitary luteinizing hormone, for immunoassay. Acta Endocrinol (Copenh) (1978) 0.80
Nocturnal desaturation and serum erythropoietin: a study in patients with chronic obstructive pulmonary disease and in normal subjects. Clin Sci (Lond) (1993) 0.80
Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment. Br J Haematol (1990) 0.80
An evaluation of short-term exposures to metalworking fluids in small machine shops. AIHAJ (2001) 0.80
Editorial retrospective. Iron loading in thalassemia--five years with the pump. N Engl J Med (1983) 0.79
Relationship between erythropoiesis and the enhanced intestinal uptake of ferric iron in hypoxia in the mouse. Br J Haematol (1986) 0.79
Erythropoietin and cord blood haemoglobin in the regulation of human fetal erythropoiesis. Br J Obstet Gynaecol (1983) 0.79
Correction of the anaemia of chronic renal failure with erythropoietin: pharmacokinetic studies in patients on haemodialysis and CAPD. Contrib Nephrol (1989) 0.79
Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy. J Clin Pathol (1994) 0.78
Storage iron exchange in the rat as affected by deferoxamine. J Lab Clin Med (1985) 0.78
Quality assurance for point-of-care testing of oral anticoagulation: a large-scale evaluation of the Hemochron Junior Signature Microcoagulation System. Int J Lab Hematol (2007) 0.78
Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias. Br J Haematol (1992) 0.78
Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes. Eur J Haematol (1990) 0.77
Distribution of iron in maternal and foetal tissues from pregnant rhesus monkeys treated with a single intravenous infusion of [59Fe] iron dextran. Br J Pharmacol Chemother (1966) 0.77
Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias. Haematologia (Budap) (1984) 0.77
The management of iron chelation therapy. Br J Haematol (1983) 0.77
The gene encoding protein kinase SEK1 maps to mouse chromosome 11 and human chromosome 17. Genomics (1996) 0.77
Erythrokinetics and iron status in heterozygous beta thalassaemia, and the effect of interaction with alpha thalassaemia. Br J Haematol (1987) 0.77
Deferiprone for thalassaemia. Lancet (2000) 0.76
Serum immunoreactive erythropoietin in children with cyanotic and acyanotic congenital heart disease. Blood (1987) 0.76
Hyperferritinaemia associated with splenic infarction. J Clin Pathol (1987) 0.75
Infiltration of central nervous system in adult acute myeloid leukaemia. Br Med J (1979) 0.75
Control of anesthetic gases in dental operatories. Scand J Work Environ Health (1992) 0.75
The pathology of butterfly densities in uraemia. Thorax (1967) 0.75
Stepwise correction of anaemia by subcutaneous administration of human recombinant erythropoietin in patients with chronic renal failure maintained by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (1991) 0.75
Correction by erythropoietin of anaemia in autonomic failure. Lancet (1991) 0.75
Tumors and immunological response in rhesus monkeys born after in utero inoculation with Rous sarcoma virus. J Natl Cancer Inst (1967) 0.75
Quantitative measurement of faecal blood loss: comparison of radioisotopic and chemical analyses. J Clin Pathol (1991) 0.75
Iron and folate supplements during pregnancy. BMJ (1988) 0.75
Acquired immunodeficiency with disseminated cryptococcosis. Arch Dis Child (1986) 0.75
The effect of the submandibular salivary gland on the erythropoietin response to hypoxia in mice with chronic renal failure. Exp Hematol (1994) 0.75
Red cell kinetics in thalassaemia intermedia. Br J Haematol (1985) 0.75
Serum prolactin as an index of dopamine receptor blockade in acute schizophrenia [proceedings]. Br J Clin Pharmacol (1977) 0.75
Invalidity from nonparallelism in a radioimmunoassay for erythropoietin accounted for by human serum antibodies to rabbit IgG. Exp Hematol (1993) 0.75
Serum immunoreactive erythropoietin and erythropoiesis in protein-energy malnutrition. Br J Haematol (1985) 0.75
Calibration of replacement standards for radioimmunoassay: a method for comparison of dose-response curves given by several preparations in a single assay [proceedings]. J Endocrinol (1978) 0.75
Changes in concentrations of ATP and other nucleotides in erythrocytes during erythropoietin treatment in haemodialysis patients. Biochem Soc Trans (1992) 0.75
Radioimmunoassay and saturation analysis. Standardization and standards. Br Med Bull (1974) 0.75
Comparisons of human, rat and mouse erythropoietins by isoelectric focusing: differences between serum and urinary erythropoietins. Br J Haematol (1991) 0.75
The effect of bilateral removal of the submandibulary salivary glands on the erythropoietic response of mice. Exp Hematol (1993) 0.75
Timing of the appearance of multipotential and committed haemopoietic progenitors in peripheral blood after mobilization in patients with lymphoma. Clin Lab Haematol (2001) 0.75
Unreliability in immunoassays of erythropoietin: anomalous estimates with an assay kit. Br J Haematol (1993) 0.75
Yersinia and iron. Lancet (1987) 0.75
An International Collaborative Study of the assay of human placental lactogen: Establishment of WHO International Reference Preparation of human placental lactogen. Br J Obstet Gynaecol (1978) 0.75